Patient reviews of Orlistat paint a picture that is more nuanced than most weight loss medication discussions acknowledge — some patients find it highly effective and straightforward to use, while others find the gastrointestinal side effects a significant barrier to long-term adherence. Understanding what drives these very different experiences, and whether Orlistat is likely to be effective for your specific circumstances, requires looking beyond the star ratings and understanding the clinical reality of how this medication works, who it works best for, and where its limitations lie. Orlistat has been available in the UK for decades and has one of the most robust evidence bases of any weight loss treatment — but it is also unique among weight loss medications in that its side effects are directly linked to patient behaviour, meaning that diet choices during treatment have a significant and immediate impact on tolerability. Whether the reviews you have read are positive or negative often reflects diet adherence as much as the medication itself. At The Care Pharmacy, our prescribing team helps patients across the UK understand which weight loss treatment is most appropriate for their circumstances — and sometimes that means Orlistat, and sometimes it means something else entirely.
Ready to find out which weight loss treatment is right for you? Get in touch with our team, or complete our online consultation to explore your weight loss treatment options today.
Quick Answer
Orlistat reviews are consistently polarised — patients who follow a low-fat diet during treatment tend to report good tolerability and meaningful weight loss, while those who consume a higher-fat diet experience significant gastrointestinal side effects that lead many to discontinue the medication. Orlistat works by blocking approximately one third of dietary fat absorption, meaning fat that is not absorbed must be excreted — and when dietary fat intake is high, the consequences are immediate and unpleasant. Clinical evidence supports Orlistat as an effective weight loss aid when used correctly, producing average weight loss of approximately 5–7% of body weight over one year when combined with a calorie-reduced, low-fat diet. For patients who are not suitable for or who have not responded well to Orlistat, alternative prescription options including GLP-1 medications such as Mounjaro or Wegovy — now also available as an oral tablet — may produce significantly greater weight loss with a different side effect profile. Whether Orlistat is worth it depends almost entirely on dietary commitment — for patients who can consistently maintain a low-fat diet, it is a clinically effective and well-tolerated option.
Orlistat is a lipase inhibitor — it works by blocking the enzyme lipase in the digestive system that is responsible for breaking down dietary fat. When lipase is inhibited, approximately one third of the fat consumed in a meal cannot be digested and absorbed. Instead, it passes through the digestive tract unabsorbed and is excreted in the stool.
This mechanism is fundamentally different from every other prescription weight loss medication currently available in the UK. GLP-1 medications such as Mounjaro and Wegovy work centrally — they act on appetite centres in the brain and slow gastric emptying to reduce hunger and caloric intake. Orlistat works peripherally — it does not affect appetite or the central nervous system at all. It simply reduces the number of calories absorbed from fat in each meal.
Key facts about Orlistat:
Across major UK review platforms and patient forums, Orlistat reviews cluster into two distinct groups — and the divide between them is almost entirely explained by dietary adherence during treatment.
The pattern in positive reviews:
Patients who report positive experiences with Orlistat almost universally mention that they had already made — or were committed to making — significant dietary changes before starting the medication. For these patients, Orlistat provides meaningful additional weight loss on top of what dietary changes alone would produce, with manageable or absent gastrointestinal side effects because their fat intake is already low enough to prevent significant unabsorbed fat excretion.
These patients also frequently report that the immediate feedback mechanism of Orlistat — the direct gastrointestinal consequences of eating too much fat — serves as a powerful behavioural reinforcement tool. In effect, the medication provides an immediate, tangible consequence for dietary lapses that some patients find more motivating than the long-term, abstract consequences of unhealthy eating.
The pattern in negative reviews:
Patients who report negative experiences with Orlistat overwhelmingly cite the gastrointestinal side effects — oily stools, urgent bowel movements, faecal incontinence, and flatulence with oily discharge — as the primary reason for discontinuing. In many of these cases, the side effects are a direct and predictable consequence of continuing to eat a high-fat diet while taking Orlistat, rather than an unpredictable adverse reaction to the medication itself.
The disconnect between expectation and experience is a clinically important theme in negative Orlistat reviews. Patients who begin treatment without a clear understanding that dietary fat restriction is essential — not optional — are significantly more likely to have a negative experience and to discontinue the medication prematurely.
Understanding the characteristics of patients who tend to have positive Orlistat experiences helps clarify whether it is likely to be a good fit for your circumstances.
Patients who tend to report the best results with Orlistat share several common characteristics:
Equally important is understanding the characteristics of patients who tend to have negative experiences — because for some of these patients, a different treatment would simply be more appropriate, regardless of dietary adherence.
Patients who tend to struggle with Orlistat include:
If you recognise your circumstances in the second list, get in touch with our prescribing team to discuss whether an alternative treatment may be more appropriate for you.
The gastrointestinal side effects of Orlistat are the single most discussed aspect of every patient review platform — and they deserve a clear, honest explanation.
When dietary fat intake exceeds the threshold that Orlistat can prevent from being absorbed, the excess unabsorbed fat causes predictable gastrointestinal effects:
The critically important clinical point is that these effects are almost entirely avoidable with appropriate dietary fat restriction. Keeping fat intake to no more than 15 grams per meal significantly reduces the likelihood and severity of GI side effects. Patients who maintain this consistently throughout treatment typically report minimal or no side effects — while those who do not consistently adhere to the dietary restriction report the full range of effects described above.
The table below compares Orlistat with the most commonly prescribed alternatives to help patients understand where it sits within the current UK weight loss treatment landscape:
One notable development worth highlighting for patients who prefer an oral medication: Wegovy (semaglutide) is now available as an oral tablet in the UK following MHRA approval — making it the first GLP-1 weight loss medication in pill form available in the UK. For patients who want significantly greater weight loss than Orlistat typically produces but prefer not to inject, the Wegovy tablet is a genuinely important new option worth discussing with a prescriber. Complete our online consultation to find out whether it may be right for you.
Based on the clinical evidence and the consistent patterns in patient reviews, the honest answer is: it depends entirely on the patient.
Orlistat is worth it if:
Orlistat may not be the right choice if:
Here are the questions patients most commonly ask our prescribing team about Orlistat:
Yes — clinical evidence consistently supports Orlistat as an effective weight loss aid when combined with a calorie-reduced, low-fat diet, producing average weight loss of approximately 5–7% of body weight over one year. Results are meaningfully greater than diet alone for most patients who adhere to the dietary requirements throughout the treatment course.
The gastrointestinal side effects reported in negative Orlistat reviews are almost always a direct consequence of consuming too much dietary fat while taking the medication — they are predictable and largely avoidable with appropriate dietary adherence rather than inherent adverse reactions to the drug itself. Patients who maintain fat intake at no more than 15 grams per meal consistently report significantly fewer and less severe side effects than those who do not adhere to the dietary requirements.
Orlistat begins reducing fat absorption from the first dose, as its mechanism is localised to the digestive tract and does not require a build-up period in the bloodstream. Meaningful weight loss typically becomes visible within four to twelve weeks of consistent use alongside a calorie-reduced, low-fat diet, with results building progressively over the following months.
Orlistat interacts with several commonly prescribed medications including ciclosporin, levothyroxine, warfarin, and antiepileptic drugs, as it can reduce their absorption and therefore their efficacy. Always provide a complete list of all medications and supplements at your consultation — your prescriber will identify any relevant interactions and advise on whether Orlistat is appropriate for your circumstances.
Orlistat 120mg is available on NHS prescription for eligible patients — typically those with a BMI of 30 or above (or 28 or above with obesity-related health conditions) who have already made dietary changes and who meet the criteria for ongoing prescribing through a structured weight management programme. The 60mg OTC version (Alli) is available without a prescription from pharmacies for patients with a BMI of 28 or above.
Stopping Orlistat means that full dietary fat absorption resumes immediately — patients who have been relying on the medication to reduce fat absorption may notice increased weight gain if dietary habits do not change to account for the return to full absorption. Sustainable weight maintenance after stopping Orlistat requires the dietary and lifestyle habits embedded during treatment to be continued without the pharmacological support.
Orlistat is a clinically effective, well-evidenced weight loss medication for the right patient — one who is committed to dietary fat restriction and who has realistic expectations of what 5–7% weight loss can achieve for their health. The polarised nature of patient reviews reflects not a flaw in the medication but a fundamental mismatch between some patients’ expectations and the dietary commitment that makes it work.
Patients who need greater weight loss, who cannot maintain a low-fat diet, or who want appetite suppression alongside fat restriction will find that GLP-1 medications such as Mounjaro and Wegovy — including the new oral Wegovy tablet — deliver significantly better outcomes for their circumstances. There is no universally right weight loss medication, only the one that is most appropriate for your individual presentation.
At The Care Pharmacy, our pharmacist-led prescribing team is here to help you make that distinction — honestly and without pushing you towards any particular product. Whether Orlistat is the right answer for you or something more potent is needed, our team will assess your full picture and recommend accordingly.
Every question about your weight loss options deserves a clear and clinically informed answer — get in touch with our prescribing team, or complete our online consultation to find out which weight loss treatment is right for you.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: July 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Orlistat on the NHS is available — but navigating the eligibility criteria, waiting times, and ongoing prescribing conditions that come with NHS access is a process that leaves many patients either ineligible, frustrated, or waiting far longer than they would like. Understanding exactly what the NHS will and will not provide, and under what conditions, […]
If you are experiencing mounjaro constipation, you are not alone. Constipation is a well recognised side effect of Mounjaro and other GLP-1 based weight loss treatments. For many people, it is mild and temporary. For others, it can be uncomfortable enough to affect daily life and confidence in continuing treatment. From the perspective of The […]
Many people ask is type 2 diabetes genetic, especially if the condition runs in their family. At The Care Pharmacy, we support patients across the UK who want clear, reliable information about their diabetes risk and the steps they can take to protect their long-term health. While genetics can play a role, type 2 diabetes […]
Obesity is a growing global health concern, with millions of people seeking effective solutions to manage their weight. Recently, a new medication called Amycretin has gained attention for its potential in treating obesity. Developed by Novo Nordisk, a leading pharmaceutical company known for its innovations in diabetes and obesity management, Amycretin has shown promising results […]
Losing weight can be both challenging and rewarding. However, Wegovy assists your weight loss journey by helping you lose more weight than is possible with diet and exercise alone. If you have recently started taking Wegovy or are planning to, you must be wondering how soon you’ll start seeing its results. Please keep reading to […]
Most of us are busy in the hustle and bustle of daily life, and we’re all looking for convenient solutions to improve our health and well-being. Like other weight loss injections, Wegovy is a highly effective medication, especially for people struggling with obesity. According to a 68-week research study, 83% of adults taking Wegovy lost […]
